The first human trial of a treatment using induced pluripotent stem cells has received conditional approval from an institutional review board in Japan.
The Scientist
Most Recent
A study suggests that some mouse models do not accurately mimic human molecular mechanisms of inflammatory response, but other mouse strains may fare better.
Tuberculosis bacteria find shelter from drugs and the body’s defenses in bone marrow stem cells.
Meet the bacterium that pulls gold ions out of solution and forms tiny nuggets of the precious metal.
One of the most advanced tuberculosis vaccines has failed to protect infants from getting the disease in a clinical trial, but it may be effective in adults.
With dogged persistence and an unwillingness to entertain defeat, Bruce Beutler discovered a receptor that powers the innate immune response to infections—and earned his share of a Nobel Prize.
Some of these insidious viruses expertly subvert the host immune system, allowing their unhindered proliferation.
Scientists use virus-free gene therapy on patient-derived stem cells to repair spinal muscular atrophy in mice.
Researchers and biotech companies are bringing a universal flu vaccine closer to reality.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
